Dr John Ingram
Projects as PI
1 of 2
- An observational cross-sectional study to describe the patient profile and secondary care management pathways for patients with hidradenitus in the UK (01/07/2015 - 31/07/2016)
- Cochrane review: Fumaric acid esters for psoriasis (10/06/2012 - 09/06/2013)
- Optimising Psoriasis referrals from primary care: Dermatology life quality index as a triage tool (01/04/2012 - 31/03/2014)
- Point of care tests to assist antibiotic prescribing decisions for diabetic foot ulcer infections (INDUCE) (01/09/2013 - 31/12/2016)
- Putting hidradenitis suppurativa on the NHS map: Antibiotic stewardship, epidemiology and core outcomes domains (01/10/2014 - 30/09/2019)
Projects as Co-Investigator
1 of 2
- A Phase 3B multicentre, randomised, placebo, controlled, double-blind, double dummy, study of the efficacy and safety of apremilast, entercept and placebo in subjects with moderate to severe plaque Psoriasis (05/04/2013 - 03/04/2015)
- A study of the effect of OC000459 on signs and symptoms in subjects with moderate to severe atopic dermatitis: A randomised double-blind placebo controlled parallel group study (14/01/2014 - 13/07/2015)
- Clinical Trial (17/02/2014 - 31/07/2016)
- Phase 2, randomised, double blind study of efficacy and safety of 2 dose levels of LDE225 in patients with locally advanced or metastatic basal cell carcinoma (09/10/2011 - 31/10/2015)
- QA multicentre, randomised, double blind, placebo controlled, dose ranging study to evaluate the safety of GSK2586184 in patients with chronic plaque psoriasis (31/03/2013 - 30/05/2014)
